Zeugma hyperbaric chambers by HPO Tech cost about $15,000 for the 1.5 ATA Wellness model and $80,000 to $90,000+ for the 3.0 ATA Medical model. All are CE-marked aluminum hard shells with ASME PVHO-1 available, and none is FDA cleared.
The Zeugma hyperbaric chamber has no public list price. HPO Tech quotes each unit, and comparable monoplace hard-shell chambers put it at roughly $40,000 to $80,000+ before US shipping, duties and installation.
Cheap hyperbaric chambers from Alibaba or Amazon cost 40 to 70% less, but they typically lack FDA 510(k) clearance, ASME PVHO-1 certification and an enforceable US warranty. Here is what that discount really costs you.
A soft shell hyperbaric chamber is an inflatable fabric chamber that reaches 1.3 ATA on air or concentrator oxygen. The FDA has cleared it only for acute mountain sickness, so other uses are off label and fall short of clinical HBOT.
A hyperbaric chamber helps chronic wounds heal by delivering 100% oxygen at 2.0 to 2.5 ATA. In the double-blind HODFU trial, 52% of diabetic foot ulcers healed at one year with HBOT versus 29% with standard care.
A Perry hyperbaric chamber is an FDA-cleared clinical HBOT chamber; new monoplace units typically sell for $80,000 to $150,000 and multiplace systems for $250,000 to $500,000 or more. Perry Baromedical also makes the BARA-MED line it acquired from ETC in 2020.
EWOT (exercise with oxygen therapy) and HBOT (hyperbaric oxygen therapy) both raise the oxygen you breathe, but only HBOT adds pressure, dissolving 10 to 15 times more oxygen into plasma at 2.0 to 2.4 ATA. HBOT has 14 FDA-cleared indications; EWOT has no clinical trials of its own.
A used hyperbaric chamber for sale typically costs 40 to 60% less than new, from about $1,500 for soft-shell units to $20,000 to $60,000 for certified pre-owned clinical systems. Here is where to buy and what to verify first.
A decompression chamber treats divers with decompression sickness and gas embolism by raising pressure while they breathe 100% oxygen, shrinking nitrogen bubbles and oxygenating injured tissue, usually on Treatment Table 6 at 2.8 ATA.